WallStreetZenWallStreetZen

NASDAQ: VCYT
Veracyte Inc Stock Forecast, Predictions & Price Target

Analyst price target for VCYT

Based on 6 analysts offering 12 month price targets for Veracyte Inc.
Min Forecast
$22.00-17.51%
Avg Forecast
$30.00+12.49%
Max Forecast
$35.00+31.23%

Should I buy or sell VCYT stock?

Based on 6 analysts offering ratings for Veracyte Inc.
Buy
Strong Buy
1 analysts 16.67%
Buy
4 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 16.67%

Be the first to know when Wall Street analysts revise their VCYT stock forecasts and price targets.

VCYT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
ScotiaBank
Top 21%
80
BuyInitiates Coverage On$33.00+23.73%2023-01-05
Morgan Stanley
Bottom 5%
5
Strong SellMaintains$22.00-17.51%2022-11-04
Raymond James
Bottom 2%
2
BuyMaintains$27.00+1.24%2022-11-04
Needham
Bottom 1%
1
BuyMaintains$33.00+23.73%2022-11-03
SVB Leerink
Bottom 2%
2
BuyMaintains$35.00+31.23%2022-11-03
Stephens & Co.
Bottom 19%
19
Strong BuyMaintains$30.00+12.49%2022-05-05
Anonymous
Stephens & Co.
Strong BuyMaintains$44.00+64.98%2022-03-02

1 of 1

Forecast return on equity

Is VCYT forecast to generate an efficient return?
Company
-1.44%
Industry
3.94%
Market
47.84%
VCYT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VCYT forecast to generate an efficient return on assets?
Company
-1.34%
Industry
1.79%
VCYT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VCYT earnings per share forecast

What is VCYT's earnings per share in the next 2 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$0.57
Avg 2 year Forecast
-$0.21

VCYT revenue forecast

What is VCYT's revenue in the next 2 years based on estimates from 5 analysts?
Avg 1 year Forecast
$316.7M+11.67%
Avg 2 year Forecast
$370.6M+30.67%
VCYT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VCYT revenue growth forecast

How is VCYT forecast to perform vs Biotechnology companies and vs the US market?
Company
11.67%
Industry
301.54%
Market
70.63%
VCYT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VCYT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VCYT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VCYT$26.67$30.00+12.49%Buy
ARVN$35.10$73.77+110.17%Buy
BCRX$10.55$14.25+35.07%Hold
SWTX$31.69$59.75+88.55%Strong Buy
RXRX$9.64$12.33+27.94%Buy

Veracyte Stock Forecast FAQ

Is Veracyte Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: VCYT) stock is to Buy VCYT stock.

Out of 6 analysts, 1 (16.67%) are recommending VCYT as a Strong Buy, 4 (66.67%) are recommending VCYT as a Buy, 0 (0%) are recommending VCYT as a Hold, 0 (0%) are recommending VCYT as a Sell, and 1 (16.67%) are recommending VCYT as a Strong Sell.

If you're new to stock investing, here's how to buy Veracyte stock.

What is VCYT's earnings growth forecast for 2023-2024?

(NASDAQ: VCYT) Veracyte's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 17.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 84.98%.

Veracyte's earnings in 2023 is -$43,244,000.On average, 5 Wall Street analysts forecast VCYT's earnings for 2023 to be -$40,899,151, with the lowest VCYT earnings forecast at -$57,402,317, and the highest VCYT earnings forecast at -$22,960,927.

In 2024, VCYT is forecast to generate -$15,068,108 in earnings, with the lowest earnings forecast at -$35,876,448 and the highest earnings forecast at -$2,152,587.

What is VCYT's revenue growth forecast for 2023-2024?

(NASDAQ: VCYT) Veracyte's forecast annual revenue growth rate of 11.67% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 301.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.63%.

Veracyte's revenue in 2023 is $283,575,000.On average, 5 Wall Street analysts forecast VCYT's revenue for 2023 to be $22,722,635,352, with the lowest VCYT revenue forecast at $22,099,891,968, and the highest VCYT revenue forecast at $23,031,962,087.

In 2024, VCYT is forecast to generate $26,588,824,895 in revenue, with the lowest revenue forecast at $25,113,513,600 and the highest revenue forecast at $27,735,364,420.

What is VCYT's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: VCYT) forecast ROA is -1.34%, which is lower than the forecast US Biotechnology industry average of 1.79%.

What is VCYT's Price Target?

According to 6 Wall Street analysts that have issued a 1 year VCYT price target, the average VCYT price target is $30.00, with the highest VCYT stock price forecast at $35.00 and the lowest VCYT stock price forecast at $22.00.

On average, Wall Street analysts predict that Veracyte's share price could reach $30.00 by Jan 5, 2024. The average Veracyte stock price prediction forecasts a potential upside of 12.49% from the current VCYT share price of $26.67.

What is VCYT's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: VCYT) Veracyte's current Earnings Per Share (EPS) is -$0.59. On average, analysts forecast that VCYT's EPS will be -$0.57 for 2023, with the lowest EPS forecast at -$0.80, and the highest EPS forecast at -$0.32. In 2024, VCYT's EPS is forecast to hit -$0.21 (min: -$0.50, max: -$0.03).

What is VCYT's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: VCYT) forecast ROE is -1.44%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.